Skip to main content
. 2012 Sep 17;4:309–323. doi: 10.2147/CMAR.S33248

Figure 6.

Figure 6

In animals with implanted GBM, compared to control animals with tumors and no treatment, GCLRP treated animals showed increased monocytes (CD115+) in the blood (A) and significantly upregulated expression of key surface markers (BE).

Abbreviations: GBM, glioblastoma; GCLRP, peptide mimetic of a ligand of C-type lectin receptor; CD, cluster of differentiation.